These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21941957)

  • 1. Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.
    Kato R; Hasegawa K; Achiwa Y; Okamoto H; Torii Y; Oe S; Udagawa Y
    Eur J Gynaecol Oncol; 2011; 32(4):381-6. PubMed ID: 21941957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity of uterine cervical cancer demonstrated by the histoculture drug response assay.
    Lee SW; Kim YM; Kim MB; Kim DY; Kim JH; Nam JH; Kim YT
    Tohoku J Exp Med; 2009 Dec; 219(4):277-82. PubMed ID: 19966525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on chemosensitivity of oral squamous cell carcinomas by histoculture drug response assay.
    Ariyoshi Y; Shimahara M; Tanigawa N
    Oral Oncol; 2003 Oct; 39(7):701-7. PubMed ID: 12907210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer.
    Hoffman RM; Jung PS; Kim MB; Nam JH
    Methods Mol Biol; 2018; 1760():73-81. PubMed ID: 29572795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
    Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer.
    Fujita Y; Hiramatsu M; Kawai M; Nishimura H; Miyamoto A; Tanigawa N
    Oncol Rep; 2009 Feb; 21(2):499-505. PubMed ID: 19148528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemosensitivity test for gastric carcinoma].
    Kubota T
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
    Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
    Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.
    Hoffman RM; Tanino H
    Methods Mol Biol; 2018; 1760():93-100. PubMed ID: 29572797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Li Y; Zeng J; Huang M; An J; Bai P; Wu L; Zhang R
    Cancer; 2017 Feb; 123(3):420-425. PubMed ID: 27696395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histoculture drug response assay on non-small cell lung cancer].
    Yoshimasu T; Oura S; Maebeya S; Tanino H; Bessho T; Arimoto J; Sakurai T; Matsuyama K; Naito Y; Furukawa T; Yano T; Suzuma T; Hirai I
    Gan To Kagaku Ryoho; 2000 May; 27(5):717-22. PubMed ID: 10832440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer.
    Hirano Y; Ushiyama T; Suzuki K; Fujita K
    Urol Res; 1999 Dec; 27(6):483-8. PubMed ID: 10651138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
    Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
    Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues.
    Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Ohashi N; Ito Y; Nakayama G; Koike M; Yamamura Y; Nakao A
    Int J Clin Oncol; 2006 Dec; 11(6):449-53. PubMed ID: 17180513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.